Search

The article focuses on the financial profiles of several banks in Colorado, detailing their assets, deposits, and leadership.

This article discusses the increased regulatory scrutiny for small healthcare transactions and the implementation of state pre-merger notification requirements. The Hart-Scott-Rodino (HSR) Act gives the Federal Trade Commission (FTC) and the Department of Justice's Antitrust Division (DOJ) joint jurisdiction to review transactions that exceed the HSR filing threshold. However, smaller transactions that do not require an HSR filing could elude antitrust review, leading to concerns. As a result, several states have implemented their own pre-merger notification requirements for healthcare transactions. The article provides an overview of the notification requirements in California, Illinois, and Colorado, including the covered transactions, size thresholds, contents of notification, and the notice and waiting period. The document also discusses the pre-merger notification requirements for healthcare transactions in Oregon, Rhode Island, Vermont, and Washington, including exemptions and public access to notification. The authors suggest that more states may adopt pre-merger filing requirements in the future, and parties should consult with antitrust counsel regardless of transaction size. [Extracted from the article]

The document is a notice of a competitive bond sale for the County of Saratoga, New York. The county is seeking proposals for the purchase of $24,891,935 Public Improvement (Serial) Bonds, 2024. Bids will be accepted until September 5, 2024, and the bonds will mature in annual principal installments over a period of 30 years. The document provides detailed instructions and terms for the bidding process, including the requirement to register with Fiscal Advisors Auction to submit electronic bids. The text also outlines the responsibilities of the winning bidder and provides contact information for the Issuer and Bond Counsel. [Extracted from the article]

Sensus Healthcare, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies to comply with SEC regulations and maintain transparency in their financial reporting. [Extracted from the article]

Dror Ortho-design, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3843, focusing on Dental Equipment and Supplies. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, offering transparency and accountability to investors. [Extracted from the article]

Nu-med Plus, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and must be submitted within 45 days of the close of each fiscal quarter. The company's contact information is located in Salt Lake City, Utah, and the SEC file number is 0001548123-24-000130. [Extracted from the article]

Glucotrack, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies to comply with SEC regulations and maintain transparency in their financial reporting. [Extracted from the article]

Dih Holding Us, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 15, 2024. The company operates in the Surgical and Medical Instruments and Apparatus industry, with its contact information listed as 77 Accord Park Drive, Suite D-1, Norwell, MA 02061. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a standard practice for publicly-traded companies to ensure transparency and compliance with regulatory requirements. [Extracted from the article]

Biotricity Inc. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and must be submitted within 45 days of the close of each fiscal quarter. For more information on this SEC filing, visit https://www.sec.gov/Archives/edgar/data/1630113/0001493152-24-046028-index.html. [Extracted from the article]

Nephros Inc. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on November 14, 2024. This filing provides unaudited financial statements and offers insight into the company's financial position throughout the year. The Form 10-Q is a quarterly report that must be submitted by most reporting companies within 45 days of the close of each quarter. Nephros Inc. is classified under the SIC code 3841 for Surgical and Medical Instruments and Apparatus, with contact information located in South Orange, NJ. [Extracted from the article]

Modular Medical, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a standard practice for publicly-traded companies to ensure transparency and compliance with regulatory requirements. [Extracted from the article]

Ss Innovations International, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Dynatronics Corp. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. This filing provides unaudited financial statements and offers insight into the company's financial position throughout the year. The Form 10-Q is a quarterly report that must be submitted by most reporting companies within 45 days of the close of each fiscal quarter. The SEC filing can be accessed for further information on the company's operations and financial status. [Extracted from the article]

Bellevue Life Sciences Acquisition Corp. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, offering transparency and accountability in the realm of investment and finance. [Extracted from the article]

Encision Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, offering transparency and accountability in the realm of investment and finance. [Extracted from the article]

Northview Acquisition Corp. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and must be submitted within 45 days of the close of each fiscal quarter. The company's contact information is located in New York City, and the SEC file number is 0001213900-24-098671. [Extracted from the article]

Nanovibronix, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3842, and the filing includes unaudited financial statements to provide a view of the company's financial position. Form 10-Q is a quarterly report required by most reporting companies, and this filing is part of the company's regulatory obligations. For more information, the SEC filing can be accessed on the SEC website. [Extracted from the article]

Altair International Corp. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, offering transparency and accountability in the business sector. [Extracted from the article]

Adagio Medical Holdings, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies to comply with SEC regulations and ensure transparency in their financial reporting. [Extracted from the article]

Retractable Technologies Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. This filing provides unaudited financial statements and offers insight into the company's financial position throughout the year. The Form 10-Q is a quarterly report that must be submitted by most reporting companies within 45 days of the close of each fiscal quarter. The SEC filing can be accessed for further information on the company's business, investment, and finance activities. [Extracted from the article]

Milestone Scientific Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Logicmark, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3842, and the filing included 54 documents. Form 10-Q is a quarterly report that provides unaudited financial statements and offers insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC. [Extracted from the article]

Envoy Medical, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies to comply with SEC regulations and ensure transparency in their financial reporting. The company's contact information is listed as 4875 White Bear Parkway, White Bear Lake, MN 55110, with a phone number of 651-361-8000. [Extracted from the article]

Carmell Corp. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, offering transparency and accountability in the business sector. [Extracted from the article]

Safe Pro Group Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company operates in the orthopedic, prosthetic, and surgical appliances and supplies industry. Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Electromedical Technologies, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 19, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. The company's contact information is located in Scottsdale, Arizona, and the SEC file number is 0001437749-24-035746. [Extracted from the article]

Acutus Medical, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Sharps Technology Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Petvivo Holdings, Inc. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Monogram Technologies Inc. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Naya Biosciences, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 19, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Bone Biologics Corp. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. This filing is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. The company's SIC code is 3842, and the filing can be accessed on the SEC's website for further information. [Extracted from the article]

Retinalgenix Technologies Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 18, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Aspira Women's Health Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 19, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. For more details on this SEC filing, visit https://www.sec.gov/Archives/edgar/data/926617/0001493152-24-046836-index.html. [Extracted from the article]

Renalytix Plc filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 19, 2024. This filing includes unaudited financial statements and offers insight into the company's financial status throughout the year. The Form 10-Q is a quarterly report required by most reporting companies, providing transparency about their financial position. For more details on this SEC filing, visit https://www.sec.gov/Archives/edgar/data/1811115/0000950170-24-128687-index.html. [Extracted from the article]

Celcuity Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and must be submitted within 45 days of the close of each fiscal quarter. The SEC filing for Celcuity Inc. can be accessed on the SEC's website for further information. [Extracted from the article]

Movano Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a standard practice for publicly-traded companies, offering transparency and accountability to investors. [Extracted from the article]

Mangoceuticals, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. This form is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. The filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Biocorrx Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is essential for publicly-traded companies and offers valuable information for investors and stakeholders. [Extracted from the article]

Longduoduo Co Ltd, a company in the health services sector, filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements, offering insight into the company's financial position throughout the year. This filing is a standard practice for publicly-traded companies, providing transparency and accountability to investors. For more details on the SEC filing by Longduoduo Co Ltd, refer to the official document on the SEC website. [Extracted from the article]

Star Equity Holdings, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 19, 2024. The company's SIC code is 3845, and the filing included 96 documents. Form 10-Q is a quarterly report that provides unaudited financial statements and offers insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Ludwig Enterprises, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company operates in the medical laboratories industry, with its contact information listed as 3160 NW 1 AVENUE, POMPANO BEACH FL 33064. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a standard practice for publicly-traded companies to ensure transparency and compliance with regulatory requirements. [Extracted from the article]

The article discusses Bionexus Gene Lab Corp.'s SEC Form 10-Q filing, which was posted on November 15, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. Bionexus Gene Lab Corp. is classified under the SIC code 8071 for Medical Laboratories, with contact information located in Kuala Lumpur. The filing is a formal document submitted to the SEC by publicly-traded companies, offering transparency and accountability to investors and stakeholders. [Extracted from the article]

Ethema Health Corp. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 14, 2024. The company operates under the SIC code 8062, which pertains to General Medical and Surgical Hospitals. The Form 10-Q is a quarterly report that includes unaudited financial statements, providing insight into the company's financial position throughout the year. This filing is a standard practice for publicly-traded companies and is essential for transparency and compliance with regulatory requirements. [Extracted from the article]